CAPLIPOINT.NS Balance Sheet
Caplin Point Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:40
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹2.67 Bn | ₹4.39 Bn | ₹5.30 Bn | ₹5.47 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹2.20 Bn | ₹1.17 Bn | ₹1.39 Bn | ₹2.09 Bn | CapitalWorkInProgress |
| Goodwill | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | Goodwill |
| Other Intangible Assets | ₹0.11 Bn | ₹0.13 Bn | ₹0.11 Bn | ₹0.33 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.71 Bn | ₹1.38 Bn | ₹2.79 Bn | ₹4.73 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.50 Bn | ₹0.75 Bn | ₹1.10 Bn | ₹1.37 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹6.37 Bn | ₹8.05 Bn | ₹10.75 Bn | ₹14.60 Bn | NoncurrentAssets |
| Inventories | ₹2.88 Bn | ₹3.63 Bn | ₹3.36 Bn | ₹4.29 Bn | Inventories |
| Trade Receivables | ₹3.94 Bn | ₹5.43 Bn | ₹6.32 Bn | ₹8.26 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹1.78 Bn | ₹1.39 Bn | ₹1.99 Bn | ₹0.94 Bn | CashAndCashEquivalents |
| Current Investments | ₹1.59 Bn | ₹2.38 Bn | ₹3.11 Bn | ₹3.86 Bn | CurrentInvestments |
| Other Current Assets | ₹1.48 Bn | ₹1.50 Bn | ₹2.05 Bn | ₹2.50 Bn | OtherCurrentAssets |
| Total Current Assets | ₹15.54 Bn | ₹18.92 Bn | ₹21.34 Bn | ₹25.86 Bn | CurrentAssets |
| Total Assets | ₹21.91 Bn | ₹26.97 Bn | ₹32.09 Bn | ₹40.45 Bn | Assets |
| Equity Share Capital | ₹0.15 Bn | ₹0.15 Bn | ₹0.15 Bn | ₹0.15 Bn | EquityShareCapital |
| Other Equity | ₹18.65 Bn | ₹23.01 Bn | ₹28.35 Bn | ₹35.71 Bn | OtherEquity |
| Equity Attributable to Owners | ₹18.80 Bn | ₹23.16 Bn | ₹28.50 Bn | ₹35.86 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.27 Bn | ₹0.31 Bn | ₹0.36 Bn | ₹0.44 Bn | NonControllingInterest |
| Total Equity | ₹19.07 Bn | ₹23.47 Bn | ₹28.86 Bn | ₹36.31 Bn | Equity |
| Long-term Borrowings | ₹0.00 Bn | ₹0.01 Bn | ₹0.00 Bn | ₹0.00 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹0.16 Bn | ₹0.20 Bn | ₹0.16 Bn | ₹0.29 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹0.03 Bn | ₹0.00 Bn | ₹0.01 Bn | ₹0.01 Bn | BorrowingsCurrent |
| Trade Payables | ₹1.64 Bn | ₹2.09 Bn | ₹2.18 Bn | ₹2.96 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹0.27 Bn | ₹0.36 Bn | ₹0.19 Bn | ₹0.17 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹2.68 Bn | ₹3.31 Bn | ₹3.06 Bn | ₹3.86 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹21.91 Bn | ₹26.97 Bn | ₹32.09 Bn | ₹40.45 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from CAPLIPOINT.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).